{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:23:59Z","timestamp":1792650239928,"version":"4.5.0"},"reference-count":116,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JASN"],"published-print":{"date-parts":[[2017,5]]},"abstract":"<jats:p>Hyponatremia is a common water balance disorder that often poses a diagnostic or therapeutic challenge. Therefore, guidelines were developed by professional organizations, one from within the United States (2013) and one from within Europe (2014). This review discusses the diagnosis and treatment of hyponatremia, comparing the two guidelines and highlighting recent developments. Diagnostically, the initial step is to differentiate hypotonic from nonhypotonic hyponatremia. Hypotonic hyponatremia is further differentiated on the basis of urine osmolality, urine sodium level, and volume status. Recently identified parameters, including fractional uric acid excretion and plasma copeptin concentration, may further improve the diagnostic approach. The treatment for hyponatremia is chosen on the basis of duration and symptoms. For acute or severely symptomatic hyponatremia, both guidelines adopted the approach of giving a bolus of hypertonic saline. Although fluid restriction remains the first-line treatment for most forms of chronic hyponatremia, therapy to increase renal free water excretion is often necessary. Vasopressin receptor antagonists, urea, and loop diuretics serve this purpose, but received different recommendations in the two guidelines. Such discrepancies may relate to different interpretations of the limited evidence or differences in guideline methodology. Nevertheless, the development of guidelines has been important in advancing this evolving field.<\/jats:p>","DOI":"10.1681\/asn.2016101139","type":"journal-article","created":{"date-parts":[[2017,2,7]],"date-time":"2017-02-07T20:10:18Z","timestamp":1486498218000},"page":"1340-1349","source":"Crossref","is-referenced-by-count":314,"title":["Diagnosis and Treatment of Hyponatremia: Compilation of the Guidelines"],"prefix":"10.1681","volume":"28","author":[{"given":"Ewout J.","family":"Hoorn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Zietse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2017,2,7]]},"reference":[{"key":"B1-20230829","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1681\/ASN.2012020128","article-title":"The challenge of hyponatremia.","volume":"23","author":"Adrogu\u00e9","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"B2-20230829","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/ki.2015.4","article-title":"Current treatment practice and outcomes. Report of the hyponatremia registry.","volume":"88","author":"Greenberg","year":"2015","journal-title":"Kidney Int"},{"key":"B3-20230829","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1056\/NEJMra1404489","article-title":"Disorders of plasma sodium--causes, consequences, and correction.","volume":"372","author":"Sterns","year":"2015","journal-title":"N Engl J Med"},{"key":"B4-20230829","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1530\/EJE-16-0500","article-title":"Long-term outcome of profound hyponatremia: A prospective 12 months follow-up study.","volume":"175","author":"Winzeler","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"B5-20230829","doi-asserted-by":"crossref","first-page":"960","DOI":"10.2215\/CJN.10101110","article-title":"Mortality and serum sodium: Do patients die from or with hyponatremia?","volume":"6","author":"Chawla","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"B6-20230829","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-13-1020","article-title":"Clinical practice guideline on diagnosis and treatment of hyponatraemia.","volume":"170","author":"Spasovski","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"Suppl 2","key":"B7-20230829","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1093\/ndt\/gfu040","article-title":"Clinical practice guideline on diagnosis and treatment of hyponatraemia.","volume":"29","author":"Spasovski","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"B8-20230829","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s00134-014-3210-2","article-title":"Clinical practice guideline on diagnosis and treatment of hyponatraemia.","volume":"40","author":"Spasovski","year":"2014","journal-title":"Intensive Care Med"},{"issue":"Suppl 1","key":"B9-20230829","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.amjmed.2013.07.006","article-title":"Diagnosis, evaluation, and treatment of hyponatremia: Expert panel recommendations.","volume":"126","author":"Verbalis","year":"2013","journal-title":"Am J Med"},{"key":"B10-20230829","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/j.amjmed.2013.11.016","article-title":"Panel recommendations on hyponatremia.","volume":"127","author":"Gross","year":"2014","journal-title":"Am J Med"},{"key":"B11-20230829","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1053\/j.ajkd.2014.06.001","article-title":"Diagnosis and treatment of hyponatremia.","volume":"64","author":"Adrogu\u00e9","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"B12-20230829","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1373\/clinchem.2015.242602","article-title":"Reference change values for sodium are ignored by the American and European treatment guidelines for hyponatremia.","volume":"61","author":"Tormey","year":"2015","journal-title":"Clin Chem"},{"key":"B13-20230829","doi-asserted-by":"crossref","first-page":"L1","DOI":"10.1530\/EJE-14-0392","article-title":"The clinical practice guideline on diagnosis and treatment of hyponatraemia: A response from Otsuka Pharmaceutical Europe Ltd.","volume":"171","author":"Avila","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"B14-20230829","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jama.2014.13967","article-title":"Evaluating hyponatremia.","volume":"313","author":"Cohen","year":"2015","journal-title":"JAMA"},{"key":"B15-20230829","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jpeds.2006.11.062","article-title":"Preventing a drop in effective plasma osmolality to minimize the likelihood of cerebral edema during treatment of children with diabetic ketoacidosis.","volume":"150","author":"Hoorn","year":"2007","journal-title":"J Pediatr"},{"key":"B16-20230829","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJMcps031078","article-title":"Clinical problem-solving. Mind the gap.","volume":"349","author":"Turchin","year":"2003","journal-title":"N Engl J Med"},{"key":"B17-20230829","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/jama.281.11.1022","article-title":"The rational clinical examination. Is this patient hypovolemic?","volume":"281","author":"McGee","year":"1999","journal-title":"JAMA"},{"key":"B18-20230829","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0002-9343(99)80180-6","article-title":"Combined fractional excretion of sodium and urea better predicts response to saline in hyponatremia than do usual clinical and biochemical parameters.","volume":"99","author":"Musch","year":"1995","journal-title":"Am J Med"},{"key":"B19-20230829","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0002-9343(87)90649-8","article-title":"Clinical assessment of extracellular fluid volume in hyponatremia.","volume":"83","author":"Chung","year":"1987","journal-title":"Am J Med"},{"key":"B20-20230829","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/qjmed\/hci081","article-title":"Diagnostic approach to a patient with hyponatraemia: Traditional versus physiology-based options.","volume":"98","author":"Hoorn","year":"2005","journal-title":"QJM"},{"key":"B21-20230829","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.amjmed.2010.01.013","article-title":"Utility and limitations of the traditional diagnostic approach to hyponatremia: A diagnostic study.","volume":"123","author":"Fenske","year":"2010","journal-title":"Am J Med"},{"key":"B22-20230829","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000322240","article-title":"Unexplained hyponatremia: Seek and you will find.","volume":"118","author":"Hoorn","year":"2011","journal-title":"Nephron, Physiol"},{"key":"B23-20230829","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1210\/jc.2014-2295","article-title":"Comparison between copeptin and vasopressin in a population from the community and in people with chronic kidney disease.","volume":"99","author":"Roussel","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B24-20230829","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1056\/NEJMcp066837","article-title":"Clinical practice. The syndrome of inappropriate antidiuresis.","volume":"356","author":"Ellison","year":"2007","journal-title":"N Engl J Med"},{"key":"B25-20230829","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/qjmed\/91.11.749","article-title":"Treating the syndrome of inappropriate ADH secretion with isotonic saline.","volume":"91","author":"Musch","year":"1998","journal-title":"QJM"},{"key":"B26-20230829","doi-asserted-by":"crossref","first-page":"20","DOI":"10.7326\/0003-4819-126-1-199701010-00003","article-title":"Postoperative hyponatremia despite near-isotonic saline infusion: A phenomenon of desalination.","volume":"126","author":"Steele","year":"1997","journal-title":"Ann Intern Med"},{"key":"B27-20230829","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/ndt\/gfi082","article-title":"Development of severe hyponatraemia in hospitalized patients: Treatment-related risk factors and inadequate management.","volume":"21","author":"Hoorn","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"B28-20230829","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1053\/j.ajkd.2012.11.032","article-title":"Hypertonic saline and desmopressin: A simple strategy for safe correction of severe hyponatremia.","volume":"61","author":"Sood","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"B29-20230829","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2215\/CJN.03190807","article-title":"DDAVP is effective in preventing and reversing inadvertent overcorrection of hyponatremia.","volume":"3","author":"Perianayagam","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"B30-20230829","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1210\/jc.2008-0330","article-title":"Value of fractional uric acid excretion in differential diagnosis of hyponatremic patients on diuretics.","volume":"93","author":"Fenske","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B31-20230829","article-title":"Evaluation of copeptin and commonly used laboratory parameters for the differential diagnosis of profound hyponatraemia in hospitalized patients: \u2018The Co-MED Study\u2019 [published online ahead of print September 22, 2016].","author":"Nigro","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B32-20230829","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/ki.2009.263","article-title":"Is it cerebral or renal salt wasting?","volume":"76","author":"Maesaka","year":"2009","journal-title":"Kidney Int"},{"key":"B33-20230829","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1136\/pgmj.2008.072819","article-title":"Incidence and pathophysiology of severe hyponatraemia in neurosurgical patients.","volume":"85","author":"Sherlock","year":"2009","journal-title":"Postgrad Med J"},{"key":"B34-20230829","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1097\/00003246-200211000-00028","article-title":"Cerebral salt wasting: Truths, fallacies, theories, and challenges.","volume":"30","author":"Singh","year":"2002","journal-title":"Crit Care Med"},{"key":"B35-20230829","doi-asserted-by":"crossref","first-page":"164","DOI":"10.7326\/0003-4819-102-2-164","article-title":"Hyponatremia: A prospective analysis of its epidemiology and the pathogenetic role of vasopressin.","volume":"102","author":"Anderson","year":"1985","journal-title":"Ann Intern Med"},{"key":"B36-20230829","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000119709","article-title":"Hyponatremia revisited: Translating physiology to practice.","volume":"108","author":"Hoorn","year":"2008","journal-title":"Nephron, Physiol"},{"key":"B37-20230829","doi-asserted-by":"crossref","first-page":"24","DOI":"10.7326\/0003-4819-110-1-24","article-title":"Thiazide-induced hyponatremia. Reproducibility by single dose rechallenge and an analysis of pathogenesis.","volume":"110","author":"Friedman","year":"1989","journal-title":"Ann Intern Med"},{"key":"B38-20230829","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/HJH.0000000000000423","article-title":"Thiazide-induced hyponatraemia is associated with increased water intake and impaired urea-mediated water excretion at low plasma antidiuretic hormone and urine aquaporin-2.","volume":"33","author":"Frenkel","year":"2015","journal-title":"J Hypertens"},{"issue":"Suppl 1","key":"B39-20230829","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.amjmed.2006.05.006","article-title":"Regulation of arginine vasopressin in the syndrome of inappropriate antidiuresis.","volume":"119","author":"Robertson","year":"2006","journal-title":"Am J Med"},{"key":"B40-20230829","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1200\/JCO.2013.49.1464","article-title":"Olfactory neuroblastoma with hyponatremia.","volume":"33","author":"Hoorn","year":"2015","journal-title":"J Clin Oncol"},{"key":"B41-20230829","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1210\/jcem-69-2-396","article-title":"Effect of administration of corticotropin-releasing hormone and glucocorticoid on arginine vasopressin response to osmotic stimulus in normal subjects and patients with hypocorticotropinism without overt diabetes insipidus.","volume":"69","author":"Yamada","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"B42-20230829","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/cen.13128","article-title":"The contribution of undiagnosed adrenal insufficiency to euvolaemic hyponatraemia: Results of a large prospective single-centre study.","volume":"85","author":"Cuesta","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B43-20230829","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1136\/bmj.328.7433.215","article-title":"Misinterpretation of serum cortisol in a patient with hyponatraemia.","volume":"328","author":"Smith","year":"2004","journal-title":"BMJ"},{"key":"B44-20230829","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1373\/clinchem.2009.125575","article-title":"Severe hyponatremia with high urine sodium and osmolality.","volume":"55","author":"van der Hoek","year":"2009","journal-title":"Clin Chem"},{"key":"B45-20230829","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1172\/JCI119352","article-title":"Role of renal aquaporins in escape from vasopressin-induced antidiuresis in rat.","volume":"99","author":"Ecelbarger","year":"1997","journal-title":"J Clin Invest"},{"key":"B46-20230829","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1093\/ndt\/gfq317","article-title":"Carbamazepine can induce kidney water absorption by increasing aquaporin 2 expression.","volume":"25","author":"de Bragan\u00e7a","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"B47-20230829","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/ndt\/gfm714","article-title":"Fluoxetine effect on kidney water reabsorption.","volume":"23","author":"Moyses","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"B48-20230829","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1056\/NEJMoa042743","article-title":"Nephrogenic syndrome of inappropriate antidiuresis.","volume":"352","author":"Feldman","year":"2005","journal-title":"N Engl J Med"},{"key":"B49-20230829","first-page":"R1247","article-title":"Impairment of osmotically stimulated AVP release in patients with primary polydipsia.","volume":"265","author":"Moses","year":"1993","journal-title":"Am J Physiol"},{"key":"B50-20230829","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1373\/clinchem.2005.060038","article-title":"Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin.","volume":"52","author":"Morgenthaler","year":"2006","journal-title":"Clin Chem"},{"key":"B51-20230829","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrendo.2015.224","article-title":"Copeptin in the diagnosis of vasopressin-dependent disorders of fluid homeostasis.","volume":"12","author":"Christ-Crain","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"B52-20230829","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1210\/jc.2008-1426","article-title":"Copeptin in the differential diagnosis of hyponatremia.","volume":"94","author":"Fenske","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B53-20230829","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1210\/jcem-42-4-613","article-title":"The interaction of blood osmolality and blood volume in regulating plasma vasopressin in man.","volume":"42","author":"Robertson","year":"1976","journal-title":"J Clin Endocrinol Metab"},{"key":"B54-20230829","doi-asserted-by":"crossref","first-page":"9536","DOI":"10.1523\/JNEUROSCI.1495-08.2008","article-title":"Amplification of transducer gain by angiotensin II-mediated enhancement of cortical actin density in osmosensory neurons.","volume":"28","author":"Zhang","year":"2008","journal-title":"J Neurosci"},{"key":"B55-20230829","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1681\/ASN.2013080895","article-title":"A copeptin-based classification of the osmoregulatory defects in the syndrome of inappropriate antidiuresis.","volume":"25","author":"Fenske","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B56-20230829","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1210\/jc.2012-3794","article-title":"An abnormal apelin\/vasopressin balance may contribute to water retention in patients with the syndrome of inappropriate antidiuretic hormone (SIADH) and heart failure.","volume":"98","author":"Blanchard","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B57-20230829","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/joim.12332","article-title":"Mid-regional pro-atrial natriuretic peptide and the assessment of volaemic status and differential diagnosis of profound hyponatraemia.","volume":"278","author":"Nigro","year":"2015","journal-title":"J Intern Med"},{"key":"B58-20230829","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1210\/en.2014-1257","article-title":"Apelin counteracts vasopressin-induced water reabsorption via cross talk between apelin and vasopressin receptor signaling pathways in the rat collecting duct.","volume":"155","author":"Hus-Citharel","year":"2014","journal-title":"Endocrinology"},{"key":"B59-20230829","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1515\/cclm-2012-0541","article-title":"Midregional pro-atrial natriuretic peptide in the general population\/Insights from the Gutenberg Health Study.","volume":"51","author":"Tzikas","year":"2013","journal-title":"Clin Chem Lab Med"},{"key":"B60-20230829","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJM198606123142402","article-title":"Osmotic demyelination syndrome following correction of hyponatremia.","volume":"314","author":"Sterns","year":"1986","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"B61-20230829","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.amjmed.2006.05.003","article-title":"Brain volume regulation in response to hypo-osmolality and its correction.","volume":"119","author":"Sterns","year":"2006","journal-title":"Am J Med"},{"key":"B62-20230829","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/ki.1990.78","article-title":"Treating hyponatremia: Damned if we do and damned if we don\u2019t.","volume":"37","author":"Berl","year":"1990","journal-title":"Kidney Int"},{"key":"B63-20230829","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1053\/j.ajkd.2012.09.019","article-title":"Hyponatremia and mortality: Moving beyond associations.","volume":"62","author":"Hoorn","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"B64-20230829","doi-asserted-by":"crossref","first-page":"417","DOI":"10.7326\/0003-4819-113-6-417","article-title":"Treating hyponatremia: What is all the controversy about?","volume":"113","author":"Berl","year":"1990","journal-title":"Ann Intern Med"},{"issue":"Suppl 3","key":"B65-20230829","first-page":"iii22","article-title":"Central pontine and extrapontine myelinolysis: The osmotic demyelination syndromes.","volume":"75","author":"Martin","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B66-20230829","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1093\/ndt\/gfk090","article-title":"Therapeutic approach in patients with dysnatraemias.","volume":"21","author":"Liamis","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"B67-20230829","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/ki.2009.254","article-title":"Re-induction of hyponatremia after rapid overcorrection of hyponatremia reduces mortality in rats.","volume":"76","author":"Gankam Kengne","year":"2009","journal-title":"Kidney Int"},{"key":"B68-20230829","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.amjmed.2012.06.037","article-title":"Electrolyte disorders in community subjects: Prevalence and risk factors.","volume":"126","author":"Liamis","year":"2013","journal-title":"Am J Med"},{"key":"B69-20230829","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2215\/CJN.01210211","article-title":"Hyponatremia and mortality: How innocent is the bystander?","volume":"6","author":"Hoorn","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"B70-20230829","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrneph.2012.246","article-title":"Hyponatraemia: More than just a marker of disease severity?","volume":"9","author":"Schrier","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"B71-20230829","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jemermed.2005.02.014","article-title":"Biochemical and etiological characteristics of acute hyponatremia in the emergency department.","volume":"29","author":"Hsu","year":"2005","journal-title":"J Emerg Med"},{"key":"B72-20230829","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1093\/ndt\/gfu263","article-title":"Desmopressin acetate (DDAVP)-associated hyponatremia and brain damage: A case series.","volume":"29","author":"Achinger","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"B73-20230829","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1056\/NEJM197412052912307","article-title":"Drug-induced dilutional hyponatremia.","volume":"291","author":"Moses","year":"1974","journal-title":"N Engl J Med"},{"key":"B74-20230829","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1053\/j.ajkd.2008.03.004","article-title":"A review of drug-induced hyponatremia.","volume":"52","author":"Liamis","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"B75-20230829","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0272-6386(12)80169-7","article-title":"The post-transurethral resection of prostate syndrome: Therapeutic proposals.","volume":"24","author":"Agarwal","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"B76-20230829","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/archinte.1997.00440230101013","article-title":"Glycine-induced hypo-osmolar hyponatremia.","volume":"157","author":"Ayus","year":"1997","journal-title":"Arch Intern Med"},{"key":"B77-20230829","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM200005253422107","article-title":"Hyponatremia.","volume":"342","author":"Adrogu\u00e9","year":"2000","journal-title":"N Engl J Med"},{"key":"B78-20230829","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/ndt\/17.7.1176","article-title":"Current prescriptions for the correction of hyponatraemia and hypernatraemia: Are they too simple?","volume":"17","author":"Barsoum","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"B79-20230829","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11011-010-9173-2","article-title":"100 cc 3% sodium chloride bolus: A novel treatment for hyponatremic encephalopathy.","volume":"25","author":"Moritz","year":"2010","journal-title":"Metab Brain Dis"},{"key":"B80-20230829","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.2215\/CJN.00910207","article-title":"Hypertonic saline for hyponatremia: Risk of inadvertent overcorrection.","volume":"2","author":"Mohmand","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"B81-20230829","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1053\/j.ajkd.2014.09.021","article-title":"Treatment of hyponatremic encephalopathy with a 3% sodium chloride protocol: A case series.","volume":"65","author":"Ayus","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"B82-20230829","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/0002-9343(86)90401-8","article-title":"New approach to disturbances in the plasma sodium concentration.","volume":"81","author":"Rose","year":"1986","journal-title":"Am J Med"},{"key":"B83-20230829","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/joim.12532","article-title":"Predictors of nonresponse to fluid restriction in hyponatraemia due to the syndrome of inappropriate antidiuresis.","volume":"280","author":"Winzeler","year":"2016","journal-title":"J Intern Med"},{"key":"B84-20230829","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMra1403672","article-title":"Vasopressin antagonists.","volume":"372","author":"Berl","year":"2015","journal-title":"N Engl J Med"},{"key":"B85-20230829","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2217\/fca.10.22","article-title":"Vasopressin-receptor antagonists.","volume":"6","author":"Hoorn","year":"2010","journal-title":"Future Cardiol"},{"key":"B86-20230829","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1053\/j.ajkd.2013.01.034","article-title":"Role of vaptans in the management of hyponatremia.","volume":"62","author":"Lehrich","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"B87-20230829","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1053\/j.ajkd.2010.01.013","article-title":"Vasopressin receptor antagonists for the treatment of hyponatremia: Systematic review and meta-analysis.","volume":"56","author":"Rozen-Zvi","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"B88-20230829","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/sj.ki.5000432","article-title":"Vasopressin receptor antagonists.","volume":"69","author":"Greenberg","year":"2006","journal-title":"Kidney Int"},{"key":"B89-20230829","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1681\/ASN.2009080857","article-title":"Oral tolvaptan is safe and effective in chronic hyponatremia.","volume":"21","author":"Berl","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"B90-20230829","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1056\/NEJMoa065181","article-title":"Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia.","volume":"355","author":"Schrier","year":"2006","journal-title":"N Engl J Med"},{"key":"B91-20230829","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/ki.2011.78","article-title":"Vaptans are not the mainstay of treatment in hyponatremia: Perhaps not yet.","volume":"80","author":"Gross","year":"2011","journal-title":"Kidney Int"},{"key":"B92-20230829","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1001\/jama.2012.54515","article-title":"Lixivaptan for hyponatremia--the numbers game.","volume":"308","author":"Borne","year":"2012","journal-title":"JAMA"},{"key":"B93-20230829","doi-asserted-by":"crossref","first-page":"e0124105","DOI":"10.1371\/journal.pone.0124105","article-title":"Hyponatremia improvement is associated with a reduced risk of mortality: Evidence from a meta-analysis.","volume":"10","author":"Corona","year":"2015","journal-title":"PLoS One"},{"key":"B94-20230829","first-page":"807054","article-title":"Unpredictable nature of tolvaptan in treatment of hypervolemic hyponatremia: Case review on role of vaptans.","volume":"2014","author":"Malhotra","year":"2014","journal-title":"Case Rep Endocrinol"},{"key":"B95-20230829","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s40264-016-0427-8","article-title":"Drug-induced liver injury: Highlights from a review of the 2015 literature.","volume":"39","author":"Sarges","year":"2016","journal-title":"Drug Saf"},{"key":"B96-20230829","article-title":"Application of a mechanistic model to evaluate putative mechanisms of tolvaptan drug-induced liver injury and identify patient susceptibility factors [published online ahead of print September 21, 2016].","author":"Woodhead","journal-title":"Toxicol Sci"},{"key":"B97-20230829","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/cen.12943","article-title":"Real-life experience of tolvaptan use in the treatment of severe hyponatraemia due to syndrome of inappropriate antidiuretic hormone secretion.","volume":"84","author":"Tzoulis","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B98-20230829","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1053\/j.ajkd.2015.12.024","article-title":"Tolvaptan and neurocognitive function in mild to moderate chronic hyponatremia: A randomized trial (INSIGHT).","volume":"67","author":"Verbalis","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"B99-20230829","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-2466-13-55","article-title":"A rapid and efficient way to manage hyponatremia in patients with SIADH and small cell lung cancer: Treatment with tolvaptan.","volume":"13","author":"Petereit","year":"2013","journal-title":"BMC Pulm Med"},{"key":"B100-20230829","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Effects of oral tolvaptan in patients hospitalized for worsening heart failure: The EVEREST outcome trial.","volume":"297","author":"Konstam","year":"2007","journal-title":"JAMA"},{"key":"B101-20230829","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12876-015-0297-z","article-title":"The treatment of vasopressin V2-receptor antagonists in cirrhosis patients with ascites: A meta-analysis of randomized controlled trials.","volume":"15","author":"Yan","year":"2015","journal-title":"BMC Gastroenterol"},{"key":"B102-20230829","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/ki.2014.320","article-title":"Urea for hyponatremia?","volume":"87","author":"Sterns","year":"2015","journal-title":"Kidney Int"},{"key":"B103-20230829","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0002-9343(80)90506-9","article-title":"Treatment of the syndrome of inappropriate secretion of antidiuretic hormone by urea.","volume":"69","author":"Decaux","year":"1980","journal-title":"Am J Med"},{"key":"B104-20230829","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00042752-200605000-00017","article-title":"Urea treatment for exercise-associated hyponatremia.","volume":"16","author":"Decaux","year":"2006","journal-title":"Clin J Sport Med"},{"key":"B105-20230829","doi-asserted-by":"crossref","first-page":"R184","DOI":"10.1186\/cc9292","article-title":"Treatment of euvolemic hyponatremia in the intensive care unit by urea.","volume":"14","author":"Decaux","year":"2010","journal-title":"Crit Care"},{"key":"B106-20230829","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/0167-5273(87)90040-4","article-title":"Urea treatment for water retention in hyponatremic congestive heart failure.","volume":"17","author":"Cauchie","year":"1987","journal-title":"Int J Cardiol"},{"key":"B107-20230829","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.4088\/JCP.v66n1105","article-title":"Treatment of the polydipsia-hyponatremia syndrome with urea.","volume":"66","author":"Verhoeven","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"B108-20230829","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/jama.1982.03320290017021","article-title":"Hyponatremia in the syndrome of inappropriate secretion of antidiuretic hormone. Rapid correction with urea, sodium chloride, and water restriction therapy.","volume":"247","author":"Decaux","year":"1982","journal-title":"JAMA"},{"key":"B109-20230829","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1159\/000184016","article-title":"Treatment of hyponatremic cirrhosis with ascites resistant to diuretics by urea.","volume":"44","author":"Decaux","year":"1986","journal-title":"Nephron"},{"key":"B110-20230829","doi-asserted-by":"crossref","first-page":"742","DOI":"10.2215\/CJN.06990711","article-title":"Efficacy and tolerance of urea compared with vaptans for long-term treatment of patients with SIADH.","volume":"7","author":"Soupart","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"B111-20230829","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/ki.2014.273","article-title":"Urea minimizes brain complications following rapid correction of chronic hyponatremia compared with vasopressin antagonist or hypertonic saline.","volume":"87","author":"Gankam Kengne","year":"2015","journal-title":"Kidney Int"},{"key":"B112-20230829","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1046\/j.1525-139X.2003.03015.x","article-title":"Does uremia protect against the demyelination associated with correction of hyponatremia during hemodialysis? A case report and literature review.","volume":"16","author":"Oo","year":"2003","journal-title":"Semin Dial"},{"key":"B113-20230829","doi-asserted-by":"crossref","first-page":"L5","DOI":"10.1530\/EJE-14-0393","article-title":"Clinical practice guidelines on diagnosis and treatment of hyponatraemia: Response to letter from Otsuka Ltd.","volume":"171","author":"Van Biesen","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"B114-20230829","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-014-0231-1","article-title":"Diagnosis and treatment of hyponatremia: A systematic review of clinical practice guidelines and consensus statements.","volume":"12","author":"Nagler","year":"2014","journal-title":"BMC Med"},{"key":"B115-20230829","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1053\/j.ajkd.2015.04.052","article-title":"Treatment of hyponatremic encephalopathy.","volume":"66","author":"Spital","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"B116-20230829","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.beem.2016.02.013","article-title":"A copeptin-based classification of the osmoregulatory defects in the syndrome of inappropriate antidiuresis.","volume":"30","author":"Fenske","year":"2016","journal-title":"Best Pract Res Clin Endocrinol Metab"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201705000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:28:43Z","timestamp":1786130923000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201705000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,7]]},"references-count":116,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2016101139","relation":{},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,7]]}}}